← 返回列表 › SCI 期刊 › 医学 › NAT REV CARDIOL

Nature Reviews Cardiology

NAT REV CARDIOL

Print ISSN 1759-5002 Online ISSN 1759-5010
SCIE Q1 新锐1区 Top期刊 综述期刊 医学
影响因子 2026
50.2
↑ 6.0
5年均分
46.5
5-Year IF
H 指数
105
H-Index
年发文量
52
Articles / Year
出刊频率
Monthly
Pub. Frequency
创刊年份
1915
Founded Year
出版商
Nature Portfolio
Publisher
出版国家
UK
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 2.1 个月
💰 版面费用
★★★★★
暂无
暂无APC数据,欢迎分享经验
中科院分区
2026新锐分区 新体系
大类1区
医学Medicine
小类1区
心脏和心血管系统Cardiology
中科院2025年分区 传统体系
大类1区
医学Medicine
小类1区
心脏和心血管系统Cardiology
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q1
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
心脏与心血管系统 Cardiac & Cardiovascular Systems SCIE Q1 1/237
99.6%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
心脏与心血管系统 Cardiac & Cardiovascular Systems SCIE Q1 3/199 JCI 7.04
99.0%
Scopus 指标
CiteScore
60.7
综合引用得分
SJR
11.209 Q1
SCImago Journal Rank
SNIP
8.668
Source Normalized Impact
JCI
7.04
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Nature Reviews Cardiology is a premier monthly journal published by Springer Nature, dedicated to providing authoritative and comprehensive coverage of the entire spectrum of cardiovascular medicine. With an ISSN of 1759-5002, the journal boasts an exceptional 2026 Impact Factor of 50.200, placing it firmly in the top Q1 quartile of the JCR, a testament to its profound influence and high citation within the field. The scope encompasses all major areas of cardiology, including ischemic heart disease, heart failure, arrhythmias, valvular disease, hypertension, vascular biology, and preventive cardiology, with a strong emphasis on translational research, clinical trials, and emerging therapies. Unlike traditional primary research journals, Nature Reviews Cardiology primarily publishes high-impact review articles, including comprehensive Reviews, topical Perspectives, and concise News & Views pieces that synthesize the latest advances and contextualize their clinical significance. It also features editorials, interviews, and research highlights that distill key findings from the broader literature. The target audience is broad and sophisticated, comprising academic researchers, clinical cardiologists, fellows, and healthcare professionals seeking a rigorous yet accessible synthesis of rapidly evolving knowledge. A notable feature is that the journal is subscription-based (not open access), though selected articles may be made freely available. Its standing as one of the highest-impact journals in cardiology, consistently ranking among the top titles globally, makes it an essential resource for staying at the forefront of cardiovascular science and clinical practice.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.